Skip to content
healthcare.dev

Lubiprostone

NDC 76420-778, Lubiprostone, capsule, from Asclemed USA, Inc..

Product NDC
76420-778
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214131
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-778 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE24 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package
76420-778-0176420077801100 CAPSULE in 1 BOTTLE (76420-778-01)
76420-778-307642007783030 CAPSULE in 1 BOTTLE (76420-778-30)
76420-778-607642007786060 CAPSULE in 1 BOTTLE (76420-778-60)
76420-778-907642007789090 CAPSULE in 1 BOTTLE (76420-778-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5797e57c-4e87-48d9-b16d-992f64db594f

Use it

Look up 76420-778 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-778 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-778. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.